The U.S. drug of abuse (DoA) testing market is expected to grow at a CAGR of 9.7% during the forecast period with its market size predicted to reach USD 3.6 billion by 2024. The U.S. DoA testing market is primarily driven by the stringent laws and regulations, government initiatives, and increasing awareness against drug abuse and development of advanced drug test equipment. The testing for drug abuse requires products such as immunoassay analyzers, chromatography instruments, breath analyzers, rapid test kits, and assay kits & reagents.
Download Free Report Sample At: https://www.vynzresearch.com/healthcare/us-drug-of-abuse-testing-market/request-sample
Hospitals are the largest end user for the DoA products and are also estimated to retain the largest market size during the forecast period. The category’s large size is due to the increasing number of research and drug test being conducted. The hospitals account to hold high number of tests due to the availability of products on a large scale as compared to other end users of DOA testing. Also, the presence of number of clinicians in hospitals is larger, marking its large share over others.
The government in the country is promoting educational initiatives to be delivered in school and communities, supporting prescription drug monitoring programs, implementing overdose education and naloxone distribution programs, and aggressive law enforcement efforts. The government is also supporting the investment for research and development for pain management and next-generation analgesics. This is anticipated fuel the market for DoA testing in the U.S.
The legalization of certain drugs and inability to detect low dose modified drugs are the key challenges faced by the U.S. DoA testing industry.
Some of the key players operating in the U.S. DoA testing market are Siemens AG, Danaher Corporation, Merck KGaA, Laboratory Corporation of America Holdings, Express Diagnostics Int'l, Inc., Quest Diagnostics Inc., Waters Corporation, Abbott Laboratories, Psychemedics Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and F. Hoffmann-La Roche AG.
About Vynzresearch
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.
Contact
Manager: Client Care
Toll-Free: 18882533960
Email: kundan@vynzresearch.com
Website: www.vynzresearch.com
No comments:
Post a Comment